Note: PCOS was officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) in May 2026. This article uses PCOS throughout while the transition is underway. Read our full article on the renaming here.
The short version
Weight loss is harder with PCOS for reasons that are strongly biological and nothing to do with effort. Insulin resistance, elevated androgens, and disrupted appetite hormones all work against standard weight management advice in ways that most general practice consultations do not fully explain. Understanding what is actually happening is the starting point for doing something about it.
You Have Probably Already Tried The Standard Advice
Most women with PCOS who’ve struggled to lose weight are not struggling with a lack of commitment. They have followed the advice. They have reduced their intake, increased their activity, and found that the results were smaller, slower, or less consistent than the same approach produced for people around them. That disparity has a biological explanation, and you deserve to understand it.
Insulin Resistance Is The Central Mechanism
Insulin resistance is present in an estimated 50 to 80 per cent of women with PCOS. When the body does not respond efficiently to insulin, it compensates by producing more of it. Chronically elevated insulin promotes fat storage, particularly in the abdominal region, and makes it harder for the body to break down fat and use it for energy. This means that even with a genuine caloric deficit, the body is working against fat loss in a way it would not be in a person without insulin resistence.
The same mechanism drives elevated androgens. Excess insulin stimulates the ovaries to produce more testosterone and related hormones. Those elevated androgens then promote a male pattern of fat distribution, meaning fat accumulates preferentially around the abdomen rather than the hips and thighs. The result is a metabolic environment that both resists fat loss and directs fat storage toward the area where it is hardest to shift.
Appetite Hormones Are Also Affected
Insulin resistance disrupts the normal signalling of leptin and ghrelin, the hormones that communicate hunger and satiety to the brain. Many women with PCOS describe persistent hunger even after eating adequately, strong cravings for carbohydrate-dense foods, and difficulty feeling satisfied from meals. These are not habits or preferences. They are the downstream effects of a hormonal system that is not regulating appetite in the way it is designed to.
Standard weight loss advice assumes a functional appetite regulation system. When leptin and ghrelin are dysregulated, the calorie-restriction approach becomes considerably harder to sustain, not because of willpower, but because the biological signals driving eating are louder than they should be.
What This Means Clinically
It means that the approach that would work well for someone without PCOS is not necessarily the right approach for someone with it. Managing weight in PCOS requires addressing the insulin resistance directly, through specific dietary patterns, targeted exercise, and where appropriate, medication, rather than applying a generic framework that was designed for a different metabolic environment.
If you have been told that the principles of weight loss are the same for everyone and you simply need to apply them consistently, that advice did not account for your biology. Our Shame And Obesity article addresses what happens when people internalise blame for a biologically driven difficulty.
For the full clinical picture of PCOS and weight management, including diet, exercise, sleep, mental health, fertility, and treatment options, read our PCOS And Weight Management: Everything You Need To Know master blog.
This article is general information only and not personal medical advice. Obesity assessment and treatment decisions should be made with a qualified health professional after individual clinical assessment. Not all treatments are suitable for every person.
Looking Forward
The difficulty you have experienced managing your weight with PCOS was not a failure of effort. It was a predictable outcome of a specific metabolic environment, and it has a specific clinical response. A clinical assessment that covers insulin resistance, body composition, and the full hormonal picture is where that response begins. Individual suitability for any treatment requires that assessment.
Evidence Notes
Teede, H., Deeks, A., & Moran, L. (2010). Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Medicine, 8, 41. https://doi.org/10.1186/1741-7015-8-41
Zhao, H., Zhang, J., Cheng, X., Nie, X., & He, B. (2023). Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment. Journal of Ovarian Research, 16(1), 9. https://doi.org/10.1186/s13048-022-01091-0
Book your appointmentA Final Note
This article provides general information only and is not a substitute for personalised medical or dietary advice. Individual needs and outcomes vary. If you would like personalised guidance, you can book an appointment with an Alevia clinician to discuss your individual needs and whether our services are appropriate for you.
